US FDA 'should relax drug safety disclosure rules'

摘要

A US advocacy group is asking the FDA to relax the requirement that pharmaceutical manufacturers include drug-specific safety information in direct-to-consumer (DTC) ads.Instead, the Coalition for Healthcare Communication suggests that advertisers should be required only to deliver in each DTC ad three core messages about the risks and benefits of medicines and the importance of medical advice.